BioCentury
ARTICLE | Company News

Chrysalis International, DNX Corp., BioClin Group deal

December 23, 1996 8:00 AM UTC

The companies completed their merger under which DNXX issued 2.6 million shares to the shareholders of BioClin, a clinical research organization (see BioCentury Aug. 26). Subsequently, DNXX changed it...